Metal-mediated modulation of streptococcal cysteine protease activity and its biological implications

Infection and Immunity

Volumn 82, Issue 7, 2014, Pages 2992-3001

  Krishnan, Karthickeyan Chella ^a,b   Mukundan, Santhosh ^b   Landero Figueroa, Julio A ^c   Caruso, Joseph A ^c   Kotb, Malak ^a,b,d  

^a UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

^b UNIVERSITY OF NORTH DAKOTA SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^c UNIVERSITY OF CINCINNATI   (United States)

^d VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COPPER; CYSTEINE PROTEINASE; METAL; TRANSFERRIN; ZINC;

ARTICLE; BACTERIAL SURVIVAL; BACTERIAL VIRULENCE; GENE MUTATION; GROUP A STREPTOCOCCAL INFECTION; MICROENVIRONMENT; MODULATION; MOLECULAR MECHANICS; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; STREPTOCOCCUS;

COPPER; CYSTEINE PROTEASES; DOSE-RESPONSE RELATIONSHIP, DRUG; GENE EXPRESSION REGULATION, BACTERIAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; METALS; PENTETIC ACID; PROTEOMICS; STREPTOCOCCUS PYOGENES; VIRULENCE FACTORS; ZINC;

EID: 84903137471     PISSN: 00199567     EISSN: 10985522     Source Type: Journal    
DOI: 10.1128/IAI.01770-14     Document Type: Article

References (48)

1. Johansson L, Thulin P, Low DE, Norrby-Teglund A. 2010. Getting under the skin: the immunopathogenesis of Streptococcus pyogenes deep tissue infections. Clin. Infect. Dis. 51:58-65. http://dx.doi.org/10.1086/653116.
2. Cone LA, Woodard DR, Schlievert PM, Tomory GS. 1987. Clinical and bacteriologic observations of a toxic shock-like syndrome due to Streptococcus pyogenes. N. Engl. J. Med. 317:146-149. http://dx.doi.org/10.1056/NEJM198707163170305.
3. Aziz RK, Kotb M. 2008. Rise and persistence of global M1T1 clone of Streptococcus pyogenes. Emerg. Infect. Dis. 14:1511-1517. http://dx.doi.org/10.3201/eid1410.071660.
4. Stevens DL. 1992. Invasive group A streptococcus infections. Clin. Infect. Dis. 14:2-11. http://dx.doi.org/10.1093/clinids/14.1.2.
5. Cole JN, Barnett TC, Nizet V, Walker MJ. 2011. Molecular insight into invasive group A streptococcal disease. Nat. Rev. Microbiol. 9:724-736. http://dx.doi.org/10.1038/nrmicro2648.
6. Schwartz B, Facklam RR, Breiman RF. 1990. Changing epidemiology of group A streptococcal infection in the U. S. A. Lancet 336:1167-1171. http://dx.doi.org/10.1016/0140-6736(90)92777-F.
7. Cunningham MW. 2000. Pathogenesis of group A streptococcal infections. Clin. Microbiol. Rev. 13:470-511. http://dx.doi.org/10.1128/CMR.13.3.470-511.2000.
8. Low DE, Schwartz B, McGeer A. 1998. The reemergence of severe group A streptococcal disease: an evolutionary perspective, p 93-123. In Scheld WM, Armstrong D, Hughes JM (ed), Emerging infections 1. ASM Press, Washington, DC.
9. Demers B, Simor AE, Vellend H, Schlievert PM, Byrne S, Jamieson F, Walmsley S, Low DE. 1993. Severe invasive group A streptococcal infections in Ontario, Canada: 1987-1991. Clin. Infect. Dis. 16:792-800. http://dx.doi.org/10.1093/clind/16.6.792.
10. Stevens DL. 1999. The flesh-eating bacterium: what's next? J. Infect. Dis. 179(Suppl 2):S366-S374. http://dx.doi.org/10.1086/513851.
11. Low DE. 2013. Toxic shock syndrome: major advances in pathogenesis, but not treatment. Crit. Care Clin. 29:651-675. http://dx.doi.org/10.1016/j.ccc.2013.03.012.
12. Kotb M, Norrby-Teglund A, McGeer A, El-Sherbini H, Dorak MT, Khurshid A, Green K, Peeples J, Wade J, Thomson G, Schwartz B, Low DE. 2002. An immunogenetic and molecular basis for differences in outcomes of invasive group A streptococcal infections. Nat. Med. 8:1398-1404. http://dx.doi.org/10.1038/nm1202-800.
13. Carapetis JR, Steer AC, Mulholland EK, Weber M. 2005. The global burden of group A streptococcal diseases. Lancet Infect. Dis. 5:685-694. http://dx.doi.org/10.1016/S1473-3099(05)70267-X.
14. Kotb M, Norrby-Teglund A, McGeer A, Green K, Low DE. 2003. Association of human leukocyte antigen with outcomes of infectious diseases: the streptococcal experience. Scand. J. Infect. Dis. 35:665-669. http://dx.doi.org/10.1080/00365540310015962.
15. Norrby-Teglund A, Chatellier S, Low DE, McGeer A, Green K, Kotb M. 2000. Host variation in cytokine responses to superantigens determine the severity of invasive group A streptococcal infection. Eur. J. Immunol. 30: 3247-3255. http://dx.doi.org/10.1002/1521-4141(200011)30:11<3247::AID-IMMU3247>3.0.CO;2-D.
16. Nooh MM, Nookala S, Kansal R, Kotb M. 2011. Individual genetic variations directly effect polarization of cytokine responses to superantigens associated with streptococcal sepsis: implications for customized patient care. J. Immunol. 186:3156-3163. http://dx.doi.org/10.4049/jimmunol.1002057.
17. Norrby-Teglund A, Kotb M. 2000. Host-microbe interactions in the pathogenesis of invasive group A streptococcal infections. J. Med. Microbiol. 49:849-852.
18. Liu T, Elliott S. 1965. Streptococcal proteinase: the zymogen to enzyme transformation. J. Biol. Chem. 240:1138-1142.
19. Doran JD, Nomizu M, Takebe S, Menard R, Griffith D, Ziomek E. 1999. Autocatalytic processing of the streptococcal cysteine protease zymogen: processing mechanism and characterization of the autoproteolytic cleavage sites. Eur. J. Biochem. 263:145-151. http://dx.doi.org/10.1046/j.1432-1327.1999.00473.x.
20. Chen CY, Luo SC, Kuo CF, Lin YS, Wu JJ, Lin MT, Liu CC, Jeng WY, Chuang WJ. 2003. Maturation processing and characterization of streptopain. J. Biol. Chem. 278:17336-17343. http://dx.doi.org/10.1074/jbc.M209038200.
21. Carroll RK, Musser JM. 2011. From transcription to activation: how group A streptococcus, the flesh-eating pathogen, regulates SpeB cysteine protease production. Mol. Microbiol. 81:588-601. http://dx.doi.org/10.1111/j.1365-2958.2011.07709.x.
22. Nelson DC, Garbe J, Collin M. 2011. Cysteine proteinase SpeB from Streptococcus pyogenes: a potent modifier of immunologically important host and bacterial proteins. Biol. Chem. 392:1077-1088. http://dx.doi.org/10.1515/BC.2011.208.
23. Aziz RK, Pabst MJ, Jeng A, Kansal R, Low DE, Nizet V, Kotb M. 2004. Invasive M1T1 group A Streptococcus undergoes a phase-shift in vivo to prevent proteolytic degradation of multiple virulence factors by SpeB. Mol. Microbiol. 51:123-134. http://dx.doi.org/10.1046/j.1365-2958.2003.03797.x.
24. Kansal RG, McGeer A, Low DE, Norrby-Teglund A, Kotb M. 2000. Inverse relation between disease severity and expression of the streptococcal cysteine protease, SpeB, among clonal M1T1 isolates recovered from invasive group A streptococcal infection cases. Infect. Immun. 68:6362-6369. http://dx.doi.org/10.1128/IAI.68.11.6362-6369.2000.
25. Kazmi SU, Kansal R, Aziz RK, Hooshdaran M, Norrby-Teglund A, Low DE, Halim AB, Kotb M. 2001. Reciprocal, temporal expression of SpeA and SpeB by invasiveM1T1groupAstreptococcal isolates in vivo. Infect. Immun. 69:4988-4995. http://dx.doi.org/10.1128/IAI.69.8.4988-4995.2001.
26. Lukomski S, Montgomery CA, Rurangirwa J, Geske RS, Barrish JP, Adams GJ, Musser JM. 1999. Extracellular cysteine protease produced by Streptococcus pyogenes participates in the pathogenesis of invasive skin infection and dissemination in mice. Infect. Immun. 67:1779-1788.
27. Connolly KL, Roberts AL, Holder RC, Reid SD. 2011. Dispersal of Group A streptococcal biofilms by the cysteine protease SpeB leads to increased disease severity in a murine model. PLoS One 6:e18984. http://dx.doi.org/10.1371/journal.pone.0018984.
28. Roberts AL, Connolly KL, Doern CD, Holder RC, Reid SD. 2010. Loss of the group A Streptococcus regulator Srv decreases biofilm formation in vivo in an otitis media model of infection. Infect. Immun. 78:4800-4808. http://dx.doi.org/10.1128/IAI.00255-10.
29. Kansal RG, Aziz RK, Kotb M. 2005. Modulation of expression of superantigens by human transferrin and lactoferrin: a novel mechanism in host-Streptococcus interactions. J. Infect. Dis. 191:2121-2129. http://dx.doi.org/10.1086/430386.
30. Chatellier S, Ihendyane N, Kansal RG, Khambaty F, Basma H, Norrby-Teglund A, Low DE, McGeer A, Kotb M. 2000. Genetic relatedness and superantigen expression in group A streptococcus serotype M1 isolates from patients with severe and nonsevere invasive diseases. Infect. Immun. 68:3523-3534. http://dx.doi.org/10.1128/IAI.68.6.3523-3534.2000.
31. Nooh MM, Aziz RK, Kotb M, Eroshkin A, Chuang WJ, Proft T, Kansal R. 2006. Streptococcal mitogenic exotoxin, SmeZ, is the most susceptible M1T1 streptococcal superantigen to degradation by the streptococcal cysteine protease, SpeB. J. Biol. Chem. 281:35281-35288. http://dx.doi.org/10.1074/jbc.M605544200.
32. Brylinski M, Skolnick J. 2008. A threading-based method (FINDSITE) for ligand-binding site prediction and functional annotation. Proc. Natl. Acad. Sci. U. S. A. 105:129-134. http://dx.doi.org/10.1073/pnas.0707684105.
33. Skolnick J, Brylinski M. 2009. FINDSITE: a combined evolution/structure-based approach to protein function prediction. Brief Bioinform. 10:378-391. http://dx.doi.org/10.1093/bib/bbp017.
34. Levy R, Edelman M, Sobolev V. 2009. Prediction of 3D metal binding sites from translated gene sequences based on remote-homology templates. Proteins 76:365-374. http://dx.doi.org/10.1002/prot.22352.
35. Babor M, Gerzon S, Raveh B, Sobolev V, Edelman M. 2008. Prediction of transition metal-binding sites from apo protein structures. Proteins 70:208-217. http://dx.doi.org/10.1002/prot.21587.
36. Ebert JC, Altman RB. 2008. Robust recognition of zinc binding sites in proteins. Protein Sci. 17:54-65. http://dx.doi.org/10.1110/ps.073138508.
37. Grant CL, Pramer D. 1962. Minor element composition of yeast extract. J. Bacteriol. 84:869-870.
38. Olsen JG, Dagil R, Niclasen LM, Sorensen OE, Kragelund BB. 2009. Structure of the mature Streptococcal cysteine protease exotoxin mSpeB in its active dimeric form. J. Mol. Biol. 393:693-703. http://dx.doi.org/10.1016/j.jmb.2009.08.046.
39. Gonzalez-Paez GE, Wolan DW. 2012. Ultrahigh and high resolution structures and mutational analysis of monomeric Streptococcus pyogenes SpeB reveal a functional role for the glycine-rich C-terminal loop. J. Biol. Chem. 287:24412-24426. http://dx.doi.org/10.1074/jbc.M112.361576.
40. Kagawa T, Cooney J, Baker H, McSweeney S, Liu M, Gubba S, Musser J, Baker E. 2000. Crystal structure of the zymogen form of the group A Streptococcus virulence factor SpeB: an integrin-binding cysteine protease. Proc. Natl. Acad. Sci. U. S. A. 97:2235-2240. http://dx.doi.org/10.1073/pnas.040549997.
41. Wang C-C, Houng H-C, Chen C-L, Wang P-J, Kuo C-F, Lin Y-S, Wu J-J, Lin M, Liu C-C, Huang W, Chuang W-J. 2009. Solution structure and backbone dynamics of streptopain: insight into diverse substrate specificity. J. Biol. Chem. 284:10957-10967. http://dx.doi.org/10.1074/jbc.M807624200.
42. Gryllos I, Grifantini R, Colaprico A, Jiang S, Deforce E, Hakansson A, Telford JL, Grandi G, Wessels MR. 2007. Mg(2+) signalling defines the group A streptococcal CsrRS (CovRS) regulon. Mol. Microbiol. 65:671-683. http://dx.doi.org/10.1111/j.1365-2958.2007.05818.x.
43. Gryllos I, Levin JC, Wessels MR. 2003. The CsrR/CsrS two-component system of group A Streptococcus responds to environmental Mg2+. Proc. Natl. Acad. Sci. U. S. A. 100:4227-4232. http://dx.doi.org/10.1073/pnas.0636231100.
44. Huber KL, Hardy JA. 2012. Mechanism of zinc-mediated inhibition of caspase-9. Protein Sci. 21:1056-1065. http://dx.doi.org/10.1002/pro.2090.
45. Kaul P, Sathish HA, Prakash V. 2002. Effect of metal ions on structure and activity of papain from Carica papaya. Nahrung 46:2-6. http://dx.doi.org/10.1002/1521-3803(20020101)46:1<2::AID-FOOD2gt;3.0.CO;2-1.
46. Perry D, Smyth M, Stennicke H, Salvesen G, Duriez P, Poirier G, Hannun Y. 1997. Zinc is a potent inhibitor of the apoptotic protease, caspase-3. A novel target for zinc in the inhibition of apoptosis. J. Biol. Chem. 272:18530-18533.
47. Sathish HA, Kaul P, Prakash V. 2000. Influence of metal ions on structure and catalytic activity of papain. Indian J. Biochem. Biophys. 37:18-27.
48. Velazquez-Delgado EM, Hardy JA. 2012. Zinc-mediated allosteric inhibition of caspase-6. J. Biol. Chem. 287:36000-36011. http://dx.doi.org/10.1074/jbc.M112.397752.